Health Stocks In News: GlaxoSmithKline (NYSE:GSK), AstraZeneca plc (ADR) (NYSE:AZN), Sanofi SA (NYSE:SNY), Teva Pharmaceutical Industries (NYSE:TEVA)

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for umeclidinium under the proposed brand name Incruse as a once-daily, maintenance treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD), according to GlaxoSmithKline plc (ADR) (NYSE:GSK). GlaxoSmithKline plc (ADR) (NYSE:GSK) stock opened at $56.23 in last session, and closed at $55.69, while the day range of GSK stock is $55.65 – $56.28. The stock showed a positive weekly performance of 2.50%.

Sanford C. Bernstein reaffirmed their market perform rating on shares of AstraZeneca plc (ADR) (NYSE:AZN) in a report issued on Thursday. AstraZeneca plc (ADR) (NYSE:AZN) stock opened at $66.97, in last session and closed at $66.61, by losing -0.02%. The 52 week range of AZN is $44.62 – $68.35. Company’s market capitalization is $83.92billion.

The agreement between Merck and Samsung Bioepis threatens to annihilate Sanofi SA (ADR) (NYSE:SNY)’s January victory against Eli Lilly & Co. (NYSE:LLY) in a patent infringement suit over the diabetes medicine. Sanofi SA (ADR) (NYSE:SNY) stock advanced 0.24% and finished the last session at $50.69. The EPS of the stock remained 1.93. Company’s market capitalization is $135.05billion.

The office of the New York Attorney General and the American units of Ranbaxy Laboratories Ltd. and Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) have come to terms on a settlement involving claims that an agreement between the two Big Pharma companies restricted competition unlawfully. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock opened the session at $48.40, and closed the session at $48.45. The 52 week range of the TEVA stock remained $36.26 – $49.23 and the day range was $47.92 – $48.98.